Taking on H5N1

NIH announced that a vaccine for H5N1 avian flu designed by scientists at the National Institute of Allergy and Infectious Diseases has entered clinical trials. The DNA-based vaccine is the first to start human trials, according to NIH. If all goes well with this vaccine, it could help pave the way for development of other DNA-based, rather than virus-based, vaccines.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher Alan Rabson has died at 92, the New York Times reports.

As the National Guideline Clearinghouse goes dark, the ECRI Institute says it will pick up the slack.

In Genome Research this week: sequencing method examines proteins parasite uses to evade immune system, L1 insertions in cancer, and more.

The Atlantic reports on private Facebook support groups for people who receive unexpected parentage results from direct-to-consumer genetic tests.